Loading data
IRMDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83.81 m USD | 73.24 m USD | 65.56 m USD | 53.3 m USD | 41.81 m USD |
| Cost of revenue | 19.49 m USD | 16.89 m USD | 15.4 m USD | 12.02 m USD | 9.76 m USD |
| Gross profit | 64.32 m USD | 56.35 m USD | 50.16 m USD | 41.28 m USD | 32.05 m USD |
| Research and development expense | 2.98 m USD | 2.83 m USD | 2.86 m USD | 2.28 m USD | 1.91 m USD |
| Operating profit | 26.15 m USD | 21.97 m USD | 20.04 m USD | 15.63 m USD | 9.82 m USD |
| Profit before tax | 28.36 m USD | 24.28 m USD | 21.74 m USD | 16.18 m USD | 9.84 m USD |
| Income tax expense | 5.88 m USD | 5.04 m USD | 4.55 m USD | 3.35 m USD | 510.82 k USD |
| Net income (reported basis) | 22.48 m USD | 19.23 m USD | 17.19 m USD | 12.83 m USD | 9.33 m USD |
| Basic earnings per share | 1.77 USD/share | 1.52 USD/share | 1.36 USD/share | 1.02 USD/share | 0.76 USD/share |
| Diluted earnings per share | 1.75 USD/share | 1.5 USD/share | 1.35 USD/share | 1.02 USD/share | 0.74 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.